N-terminal globin adducts as biomarkers for formation of butadiene derived epoxides

Chemico-Biological Interactions

Volumn 166, Issue 1-3, 2007, Pages 84-92

  Boysen, Gunnar ^a   Georgieva, Nadia I ^a   Upton, Patricia B ^a   Walker, Vernon E ^b   Swenberg, James A ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

Butadiene; Carcinogenesis; Protein adducts

Indexed keywords

1,2 EPOXY 3 BUTENE; 1,2 EPOXY 3,4 BUTANEDIOL; 1,3 BUTADIENE; BIOLOGICAL MARKER; BUTADIENE DIEPOXIDE; EPOXIDE; GLOBIN; N (2 HYDROXY 3 BUTENYL)VALINE; N,N (2,3 DIHYDROXY 1,4 BUTADIYL)VALINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CHEMICAL CARCINOGENESIS; CHEMICAL MUTAGENESIS; DNA ADDUCT; DOSE RESPONSE; GAS CHROMATOGRAPHY; NONHUMAN; SEX DIFFERENCE; SPECIES DIFFERENCE; TANDEM MASS SPECTROMETRY; TOXICOKINETICS;

ANIMALS; BIOLOGICAL MARKERS; BUTADIENES; EPOXY COMPOUNDS; HEMOGLOBINS; HUMANS; VALINE;

MUS; RATTUS; RODENTIA;

EID: 33947184241     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2006.10.005     Document Type: Article

References (43)

1. ATSDR. Toxicological Profile for 1,3-Butadiene. Benzene (1992), Agency for Toxic Substances and Disease Registery, U.S. Department of Health and Human Services, Public Health Service
2. Himmelstein M.W., Acquavella J.F., Recio L., Medinsky M.A., and Bond J.A. Toxicology and epidemiology of 1,3-butadiene. Crit. Rev. Toxicol. 27 (1997) 1-108
3. Törnqvist M., Fred C., Haglund J., Helleberg H., Paulsson B., and Rydberg P. Protein adducts: quantitative and qualitative aspects of their formation, analysis and applications. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 778 (2002) 279-308
4. Törnqvist M., Mowrer J., Jensen S., and Ehrenberg L. Monitoring of environmental cancer initiators through hemoglobin adducts by a modified Edman degradation method. Anal. Biochem. 154 (1986) 255-266
5. Boysen G., Georgieva N.I., Upton P.B., Jayaraj K., Li Y., Walker V.E., and Swenberg J.A. Analysis of diepoxide-specific cyclic N-terminal globin adducts in mice and rats after inhalation exposure to 1,3-butadiene. Cancer Res. 64 (2004) 8517-8520
6. Kautiainen A., Fred C., Rydberg P., and Törnqvist M. A liquid chromatography tandem mass spectrometric method for in vivo dose monitoring of diepoxybutane, a metabolite of butadiene. Rapid Commun. Mass Spectrom. 14 (2000) 1848-1853
7. Miraglia N., Basile A., Pieri M., Acampora A., Malorni L., De Giulio B., and Sannolo N. Ion trap mass spectrometry in the structural analysis of haemoglobin peptides modified by epichlorohydrin and diepoxybutane. Rapid Commun. Mass Spectrom. 16 (2002) 840-847
8. Basile A., Ferranti P., Pocsfalvi G., Mamone G., Miraglia N., Caira S., Ambrosi L., Soleo L., Sannolo N., and Malorni A. A novel approach for identification and measurement of hemoglobin adducts with 1,2,3,4-diepoxybutane by liquid chromatography/electrospray ionisation mass spectrometry and matrix-assisted laser desorption/ionisation tandem mass spectrometry. Rapid Commun. Mass Spectrom. 15 (2001) 527-540
9. Lindh C.H., Kristiansson M.H., Berg-Andersson U.A., and Cohen A.S. Characterization of adducts formed between human serum albumin and the butadiene metabolite epoxybutanediol. Rapid Commun. Mass Spectrom. 19 (2005) 2488-2496
10. Badghisi H., and Liebler D.C. Sequence mapping of epoxide adducts in human hemoglobin with LC-tandem MS and the SALSA algorithm. Chem. Res. Toxicol. 15 (2002) 799-805
11. Moll T.S., Harms A.C., and Elfarra A.A. A comprehensive structural analysis of hemoglobin adducts formed after in vitro exposure of erythrocytes to butadiene monoxide. Chem. Res. Toxicol. 13 (2000) 1103-1113
12. 14C]-butadiene. Chem. Biol. Interact. 147 (2004) 213-232
13. Rossi R., Barra D., Bellelli A., Boumis G., Canofeni S., Di Simplicio P., Lusini L., Pascarella S., and Amiconi G. Fast-reacting thiols in rat hemoglobins can intercept damaging species in erythrocytes more efficiently than glutathione. J. Biol. Chem. 273 (1998) 19198-19206
14. Hamboeck H., Fischer R.W., Di Iorio E.E., and Winterhalter K.H. The binding of s-triazine metabolites to rodent hemoglobins appears irrelevant to other species. Mol. Pharmacol. 20 (1981) 579-584
15. J.A. Swenberg, M.G. Bird, R.J. lewis, Future directions in butadiene risk assessment, Chem. Biol. Interact. (2006).
16. R.J. Albertini, R.J. Sram, P.M. Vacek, J. Lynch, J.D. Nicklas, J.D. McDonald, J.A. Swenberg, Molecular epideminological studies in 1,3-butadiene exposed Czech workers: female-male comparisons, Chem. Biol. Interact. (2006).
17. Q. Meng, L.C. Hackfield, R.M. Hodgson, L.A. Wisse, D.L. Redezke, V.E. Walker, Mutagenicity of stereochemical configurations of 1,3-butadiene epoxy metabolites, HEI Research Report, Health Effects Institute, Capital City Press, Montpelier, VT, 2006.
18. Q. Meng, D.L. Redezke, L.C. Hackfield, R.P. Hodge, D.M. Walker, V.E. Walker, Mutagenicity of stereochemical configurations of 1,2-epoxybutane and 1,2:3,4-diepoxybutane in human cells, Chem. Biol. Interact. (2006).
19. Cochrane J.E., and Skopek T.R. Mutagenicity of butadiene and its epoxide metabolites. I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts. Carcinogenesis 15 (1994) 713-717
20. Cochrane J.E., and Skopek T.R. Mutagenicity of butadiene and its epoxide metabolites. II. Mutational spectra of butadiene, 1,2-epoxybutene and diepoxybutane at the hprt locus in splenic T cells from exposed B6C3F1 mice. Carcinogenesis 15 (1994) 719-723
21. Swenberg J.A., Koc H., Upton P.B., Georgieva N., Ranasinghe A., Walker V.E., and Henderson R. Using DNA and hemoglobin adducts to improve the risk assessment of butadiene. Chem. Biol. Interact. 135/136 (2001) 387-403
22. Powley M.W., Li Y., Upton P.B., Walker V.E., and Swenberg J.A. Quantification of DNA and hemoglobin adducts of 3,4-epoxy-1,2-butanediol in rodents exposed to 3-butene-1,2-diol. Carcinogenesis 26 (2005) 1573-1580
23. Moll T.S., and Elfarra A.A. Characterization of the reactivity, regioselectivity, and stereoselectivity of the reactions of butadiene monoxide with valinamide and the N-terminal valine of mouse and rat hemoglobin. Chem. Res. Toxicol. 12 (1999) 679-689
24. Osterman-Golkar S., Kautiainen A., Bergmark E., Hakansson K., and Maki-Paakkanen J. Hemoglobin adducts and urinary mercapturic acids in rats as biological indicators of butadiene exposure. Chem. Biol. Interact. 80 (1991) 291-302
25. Albertini R.J., Sram R.J., Vacek P.M., Lynch J., Nicklas J.A., van Sittert N.J., Boogaard P.J., Henderson R.F., Swenberg J.A., Tates A.D., Ward Jr. J.B., Wright M., Ammenheuser M.M., Binkova B., Blackwell W., de Zwart F.A., Krako D., Krone J., Megens H., Musilova P., Rajska G., Ranasinghe A., Rosenblatt J.I., Rossner P., Rubes J., Sullivan L., Upton P., and Zwinderman A.H. Biomarkers in Czech workers exposed to 1,3-butadiene: a transitional epidemiologic study. Res. Rep. Health Eff. Inst. (2003) 1-141
26. Osterman-Golkar S.M., Moss O., James A., Bryant M.S., Turner M., and Bond J.A. Epoxybutene-hemoglobin adducts in rats and mice: dose response for formation and persistence during and following long-term low-level exposure to butadiene*1. Toxicol. Appl. Pharmacol. 150 (1998) 166-173
27. Lee J.H., Kang H.S., and Han D.H. Ratios of N-(2,3,4-trihydroxybutyl) valine and N-(2-hydroxy-3-butenyl) valine formed hemoglobin adducts in female mice inhalation exposure with 1,3-butadiene. Toxicol. Ind. Health 21 (2005) 15-20
28. Rydberg P., Magnusson A.L., Zorcec V., Granath F., and Törnqvist M. Adducts to N-terminal valines in hemoglobin from butadiene metabolites. Chem. Biol. Interact. 101 (1996) 193-205
29. Kirby A.J. Effective molarities for intramolecular reactions. Adv. Phys. Org. Chem. (1980) 188-277
30. Fred C., Grawe J., and Tornqvist M. Hemoglobin adducts and micronuclei in rodents after treatment with isoprene monoxide or butadiene monoxide. Mutat. Res. 585 (2005) 21-32
31. Fred C., Kautiainen A., Athanassiadis I., and Törnqvist M. Hemoglobin adduct levels in rat and mouse treated with 1,2:3,4-diepoxybutane. Chem. Res. Toxicol. 17 (2004) 785-794
32. Perez H.L., Lahdetie J., Landin H., Kilpelainen I., Koivisto P., Peltonen K., and Osterman-Golkar S. Haemoglobin adducts of epoxybutanediol from exposure to 1,3-butadiene or butadiene epoxides. Chem. Biol. Interact. 105 (1997) 181-198
33. Rohlfing C.L., Wiedmeyer H.M., Little R.R., England J.D., Tennill A., and Goldstein D.E. Defining the relationship between plasma glucose and HbA1c: analysis of glucose profiles and HbA1c in the diabetes control and complications trial. Diab. Care 25 (2002) 275-278
34. Koc H., Tretyakova N.Y., Walker V.E., Henderson R.F., and Swenberg J.A. Molecular dosimetry of N-7 guanine adduct formation in mice and rats exposed to 1,3-butadiene. Chem. Res. Toxicol. 12 (1999) 566-574
35. J.A. Swenberg, N.I. Christova-Gueorguieva, P.B. Upton, A. Ranasinghe, N. Scheller, K.Y. Wu, R. Hayes, 1,3-Butadiene: cancer, mutations, and adducts. Part V. Hemoglobin adducts as biomarkers of butadiene exposure and metabolism, HEI Report 92, Cambridge, MA, 2000, pp. 191-209.
36. J.G. Filser, C. Hutzler, V. Meischner, V. Veereshwarayya, G.A. Csanady, Metabolism of 1,3-butadiene to toxicologically relevant metabolites in single-exposed mice and rats, Chem. Biol. Interact. (2006).
37. N.I. Georgieva, G. Boysen, J. Karupiah, A. Gold, J.A. Swenberg, Quantitative analysis of N-terminal valine peptide adducts specific for 1,2-epoxy-3-butene, Chem. Biol. Interact. (2006).
38. Thornton-Manning J.R., Dahl A.R., Bechtold W.E., and Henderson R.F. Gender and species differences in the metabolism of 1,3-butadiene to butadiene monoepoxide and butadiene diepoxide in rodents following low-level inhalation exposures. Toxicology 113 (1996) 322-325
39. G. Boysen, C.O. Scarlett, B. Temple, T.P. Combs, N.L. Brooks, C.H. Borchers, J.A. Swenberg, Identification of covalent modifications in P450 2E1 by 1,2-epoxy-3-butene in vitro, Chem. Biol. Interact. (2006).
40. Oesch-Bartlomowicz B., Padma P.R., Becker R., Richter B., Hengstler J.G., Freeman J.E., Wolf C.R., and Oesch F. Differential modulation of CYP2E1 activity by cAMP-dependent protein kinase upon Ser129 replacement. Exp. Cell Res. 242 (1998) 294-302
41. Oesch-Bartlomowicz B., and Oesch F. Fast regulation of cytochrome P450 activities by phosphorylation and consequences for drug metabolism and toxicity. Biol. Chem. 383 (2002) 1587-1592
42. Blobaum A.L., Kent U.M., Alworth W.L., and Hollenberg P.F. Mechanism-based inactivation of cytochromes P450 2E1 and 2E1 T303A by tert-butyl acetylenes: characterization of reactive intermediate adducts to the heme and apoprotein. Chem. Res. Toxicol. 15 (2002) 1561-1571
43. Q. Meng, D.L. Redetzke, L.C. Hackfeld, R.P. Hodge, D.M. Walker, V.E. Walker, Mutagenicity of stereochemical configurations of 1,2-epoxybutene and 1,2:3,4-diepoxybutane in human lymphblastoid cells, Chem. Biol. Interact. (2006).